Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
First-in-human study of CLY-124 in healthy volunteers and adults with sickle cell disease
PACTR202505486265852Phase 1Recruiting
- Sponsor
- Cellarity
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1 trial of CLY-124 in sickle cell disease (SCD), sponsored by Cellarity. Started Jun 2025; status: recruiting.
02
Drugs
CLY-124
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on PACTR202505486265852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202505486265852.